Antibodies
Search   

CatalogProductSizeQtyPriceExt. Price 
Total$0.00 

 

Log in to your account to view/modify your save items list
 
 
Recombinant Human IL-10 (mammalian expressed, carrier-free)
Recombinant Human IL-10 (mammalian expressed, carrier-free)
573202 10 µg $195.00     
573204 25 µg $395.00     
573206 100 µg $1,200.00     

Product Details

 
Source: Human IL-10, amino acids Ser19-Asn178 (Accession # NM_000572), was expressed in 293E cells, using human IL-2 signal peptide.
Molecular Mass: The 160 amino acid recombinant protein has a predicted molecular mass of 18,647 Da. The DTT-reduced protein migrates at approximately 18 kD and the non-reduced protein migrates slightly with faster mobility by SDS-PAGE. The N-terminal amino acid is Serine.
Purity: >95%, as determined by Coomassie stained SDS-PAGE.
Formulation: 0.22 µm filtered protein solution is in PBS
Endotoxin Level: Less than 0.01 ng per µg cytokine as determined by the LAL method.
Preparation: 10-100 µg sizes are bottled at 200 µg/mL.
Storage & Handling: Unopened vial can be stored at 4°C for three months, at -20°C for six months, or at -70°C for one year. For maximum results, quick spin vial prior to opening. Stock solutions should be prepared at no less than 10 µg/mL in buffer containing carrier protein such as 1% BSA or HSA or 10% FBS. After dilution, the cytokine can be stored at 4°C for one month or at -20°C to -70°C for up to 3 months. Avoid repeated freeze/thaw cycles.
Activity: ED50 = 0.1 - 0.3 ng/ml corresponding to a specific activity of 3.3 - 10 x 106 units/mg, as determined by the dose dependent inhibition of IFNg production by PHA activated PBMC.
Application:

Bioassay

COA:
Enter Lot#:   
Recombinant Human IL-10 (mammalian expressed, carrier-free)  Image 1
Human IL-10 inhibits the production of IFNγ in PMA activated PBMC.




Description:

IL-10 was first described as a cytokine that is produced by T helper 2 (Th2) cell clones. It inhibits interferon (IFN)-g synthesis in Th1 cell, and therefore it was initially called ‘cytokine synthesis inhibiting factor’ (CSIF).  Macrophages are the main source of IL-10 and its secretion can be stimulated by endotoxin (via Toll-like receptor 4, NF-kB dependent), tumor necrosis factor TNF-a (via TNF receptor p55, NF-kB-dependent), catecholamines, and IL-1. IL-10 controls inflammatory processes by suppressing the expression of proinflammatory cytokines, chemokines, adhesion molecules, as well as antigen-presenting and costimulatory molecules in monocytes/macrophages, neutrophils, and T cells. IL-10 inhibits the production of proinflammatory mediators by monocytes and macrophages such as endotoxin- and IFNg-induced release of IL-1a, IL-6, IL-8, G-CSF, GM-CSF, and TNF-a. In addition, it enhances the production of anti-inflammatory mediators such as IL-1RA and soluble TNFa receptors. IL-10 inhibits the capacity of monocytes and macrophages to present antigen to T cells. This is realized by down-regulation of constitutive and IFNg-induced cell surface levels of MHC class II, of costimulatory molecules such as CD86 and of some adhesion molecules such as CD58. IL-10 belongs to a family of nine members: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, and the more distantly related IL-28A, IL-28B, and IL-29. This family of cytokines emerged before the adaptive immune response.

Other Names: Cytokine synthesis inhibitory factor (CSIF)
Distribution: IL-10 is produce by Th2 cells, macrophages, DCs, B cells, CD8+ T cells, regulatory T cells (Tregs), Th1 cells and Th17 cells. In addition, IL-10 is expressed by monocytes, B cells, eosinophils, and mast cells.
Function: IL-10 is an immunoregulatory cytokine. Its main function is the limitation and termination of inflammatory responses and the regulation of differentiation and proliferation of several immune cells such as T cells, B cells, natural killer cells, antigen-presenting cells, mast cells, and granulocytes.
Ligand Receptor: IL-10 binds to their receptors IL-10R1 and IL-10R2, and initiates a STAT3-dependent signaling cascade.
Interaction: IL-10R is expressed in monocytes, NK, B and T cells. In addition, Langerhans cells, dermal dendritic cells, eosinophils, mast cells, and endothelial cells can respond to IL-10.
Antigen
References:

1. Fiorentino DF, et al. 1989. J. Exp. Med. 170:2081.
2. Ho AS, et al. P. Natl. Acad. Sci. 1993. 90:11267.
3. Hart PH, et al. 1996. J. Immunol. 157:3672.
4. Asadullah K, et al. 2003. Pharmacol. Rev. 55:241.
5. Mosser DM and Zhang X. 2008. Immunol. Rev. 226:205.
6. Maynard CL and Weaver CT. 2008. Immunol. Rev. 226:219.
7. Ouyang W, et al. 2010. Annu. Rev. Immunol. 30:559.

GeneID: 3586
Latest Publications: View the latest IL-10 articles on HighwirePress.com
UniProt: View information about IL-10 on UniProt.org
Keywords: Recombinant Human IL-10 (mammalian expressed, carrier-free), Recombinant, IL-10 recombinant protein, recombinant IL-10 protein, Cytokine synthesis inhibitory factor (CSIF), Bioassay (Recombinants), Immunology, Antibodies
Related Products

DescriptionCloneApplications

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/terms). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

Version: 2 Revision Date: 2013-05-14
x
Copyright © 2013 BioLegend, Inc. All rights reserved.